SCHEMBL2861489

SCHEMBL2861489

CCOC(=O)c1ccc(F)cc1NC(C)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.64
KDM4E B2RXH2 7/20 0.56
LMNA P02545 6/20 0.56
ALDH1A1 P00352 3/20 0.56
POLB P06746 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56
HPGD P15428 2/20 0.56
GALR2 O43603 1/20 0.56
MITF O75030 1/20 0.56
HSP90AA1 P07900 1/20 0.56
XBP1 P17861 1/20 0.56
CCR6 P51684 1/20 0.56
GAA P10253 2/20 0.55
STAT1 P42224 1/20 0.55
RAB9A P51151 1/20 0.55
TDP1 Q9NUW8 2/20 0.54
TSHR P16473 3/20 0.53
TP53 P04637 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14854686 0.84 SMN1; SMN2 (0.51) SMN1; SMN2KDM4ELMNAALDH1A1HPGD
Hydrochloric Acid SCHEMBL6382375 0.84 KDM4E (0.52) SMN1; SMN2KDM4ELMNAPOLBNPSR1
SCHEMBL13893468 0.82 KDM4E (0.48) SMN1; SMN2KDM4ELMNAALDH1A1POLB
SCHEMBL23043521 0.82 CYP1A2 (0.64) SMN1; SMN2KDM4ELMNAALDH1A1POLB
SCHEMBL4628672 0.79 TSHR (0.60) SMN1; SMN2KDM4ELMNAALDH1A1POLB
SCHEMBL7312805 0.78 LMNA (0.71) SMN1; SMN2KDM4ELMNAALDH1A1NPSR1
SCHEMBL28890587 0.78 KDM4E (0.51) SMN1; SMN2KDM4ELMNAALDH1A1POLB
SCHEMBL7997377 0.78 SMN1; SMN2 (1.00) SMN1; SMN2KDM4ELMNAALDH1A1POLB
SCHEMBL5247862 0.78 TSHR (0.57) SMN1; SMN2KDM4ELMNAALDH1A1POLB
SCHEMBL367075 0.78 TSHR (0.57) SMN1; SMN2ALDH1A1POLBNPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 SMN1; SMN2 4812/4885KDM4E 2531/4885LMNA 1893/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 SMN1; SMN2 4781/4885KDM4E 2430/4885LMNA 1548/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 SMN1; SMN2 4812/4885KDM4E 2531/4885LMNA 1893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.